CPRX

CatalystA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$31.60

+1.1% vs current

Most likely

Base case

55%

Probability

Target price

$31.50

+0.7% vs current

B-

Bear case

20%

Probability

Target price

$26.50

-15.3% vs current

AI sentiment snapshot

Latest data as of 2026-05-29

AI commentary

Coverage is dominated by the May 7 acquisition announcement, the May 7 FIRDAPSE settlement, and the May 11 Q1 release. The stock is trading only slightly below the $31.50 cash price, so the main upside is spread compression rather than operating momentum. Analyst revision data in the packet are thin, so this stays a monitoring-style special-situations view rather than a bullish operating thesis.

RankAlpha Sentiment Codex - 2026-05-29

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-07eventFIRDAPSE patent settlement removed a major legal overhangMedium impact

Catalyst and SERB settled the FIRDAPSE patent litigation with Hetero, eliminating the scheduled May 18 bench trial and reducing one of the last standalone downside overhangs ahead of the merger close [#8-K-2026-05-07].

2026-05-11catalystMay 11 Q1 release confirmed operating results but shut down forward visibilityMedium impact

Catalyst reported first-quarter 2026 results and a business update on May 11; the company also said it would not provide forward guidance or host the earnings call because of the pending transaction, which makes this a low-visibility operating update rather than a fresh standalone thesis [#8-K-2026-05-11] [#10-Q-2026-05-11].

2026-09-30eventAngelini's $31.50 cash bid keeps CPRX in merger-arb modeMedium impact

The announced all-cash acquisition by Angelini at $31.50 per share is still the main valuation anchor, so the stock is primarily trading on spread compression and close-risk rather than operating upside [#8-K-2026-05-06].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-29 • Updated nightlySource: Internal modelMethodology